Elevance Health Inc. Common Stock vs Eli Lilly And Co — how do they compare? Elevance Health Inc. Common Stock trades at $400.15 (market cap $87.68B), while Eli Lilly And Co trades at $1,167.12 (market cap $1.06T). The key difference: Eli Lilly And Co is far larger — about 12.1× Elevance Health Inc. Common Stock's market cap, and Elevance Health Inc. Common Stock pays the higher dividend (1.7%). Which is the better fit depends on your goals.
| ELV | LLY | |
|---|---|---|
Market Cap | $87.68B | $1.06T |
Volume | 904,657 | 2,297,239 |
Sector | Health | Health |
52-Week High | $426.79 | $1.28K |
52-Week Low | $280.74 | $799.57 |
Enterprise Value | $108.49B | $1.11T |
Dividend Yield | 1.7% | 0.58% |
Typical Hold Time | — | 93 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,169.93, up 1.07% on the day, with a bullish technical signal and strong fundamental momentum. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $8.38 exceeding the $6.40 estimate. Revenue surged to $65.18 billion in 2025, driving a net income margin of 33.53%. Positive news flow highlights promising pipeline updates in weight-loss and diabetes drugs, reinforcing growth prospects.
Outlook remains favorable given dominant market position and innovation pipeline, though high valuation multiples pose a risk. Analyst consensus is strongly bullish with a $1,340 price target. Key risks include competitive pressures and execution challenges in scaling production to meet demand for blockbuster therapies.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Elevance Health provides health plans and healthcare services. Its offerings include medical, behavioral health, pharmacy, dental, vision, and complex-care solutions, including through the Carelon business.
Read more on ELV →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →